🇺🇸 FDA

Company profile · Sponsor

Phio

Phio Pharmaceuticals

PHIO · NYSE pharma KING OF PRUSSIA, PA, USA
Pipeline
2
Drugs
0
Patents
8

Quick answer

Phio (PHIO) is a pharma company. headquartered in KING OF PRUSSIA, PA, USA. listed on NYSE. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker PHIO
Exchange NYSE
Company type pharma
Headquarters KING OF PRUSSIA, PA, USA
SEC CIK 0001533040

Pipeline (2)

Search pipeline →

  1. DP CD8 TIL

    Phio

    HNSCC

    phase 1 mab active

    1 trial

  2. PH-762

    Phio

    Squamous Cell Carcinoma of the Skin

    phase 1 small molecule active

    1 trial

Patents (8)

Search patents →

  1. US 11926828

    Methods for treating aging and skin disorders using nucleic acids targeting TYR or MMP1

    Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11639359

    Bryoid compositions, methods of making and use thereof

    Expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11584933

    RNA interference in ocular indications

    Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11396654

    Neutral nanotransporters

    Expires Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11279934

    Methods for treating cancer using nucleic acids targeting MDM2 or MYCN

    Expires Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11254940

    Inhibition of MAP4K4 through RNAi

    Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11234932

    Combination HIV therapeutic

    Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11118178

    Reduced size self-delivering RNAI compounds

    Expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Phio?

Phio (PHIO) is a pharma company. headquartered in KING OF PRUSSIA, PA, USA. listed on NYSE. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does Phio sponsor?

We track 2 ClinicalTrials.gov-linked programs for Phio, including DP CD8 TIL and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Phio company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.